Welcome to our dedicated page for Accelerant Holdings news (Ticker: ARX), a resource for investors and traders seeking the latest updates and insights on Accelerant Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Accelerant Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Accelerant Holdings's position in the market.
Accelerant Holdings (NYSE:ARX) has successfully completed its upsized Initial Public Offering (IPO), selling 39,630,324 Class A common shares at $21.00 per share. The offering included 20,276,280 shares from Accelerant and 19,354,044 shares from existing shareholders, including 5,169,172 shares from the fully exercised over-allotment option.
Trading began on the New York Stock Exchange on July 24, 2025, under the ticker symbol "ARX". The IPO was led by Morgan Stanley and Goldman Sachs as lead bookrunners, with BMO Capital Markets and RBC Capital Markets serving as active bookrunners.
Accelerant Holdings (NYSE:ARX) has announced the pricing of its upsized initial public offering at $21.00 per share. The company is offering 34,461,152 Class A common shares, consisting of 20,276,280 shares from Accelerant and 14,184,872 shares from existing shareholders.
The IPO is expected to begin trading on the New York Stock Exchange on July 24, 2025, under the ticker symbol "ARX". Selling shareholders have granted underwriters a 30-day option to purchase up to an additional 5,169,172 shares. Morgan Stanley and Goldman Sachs are serving as lead bookrunners for the offering, which is expected to close on July 25, 2025.
FAQ
What is the current stock price of Accelerant Holdings (ARX)?
